The landscape of dementia prognosis has evolved significantly with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years ahead of symptoms emerge. When these technological advances stand for amazing development in understanding neurodegenerative i